KPWS
GILD icon

Kestra Private Wealth Services’s Gilead Sciences GILD Stock Holding History

Kestra Private Wealth Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98M Sell
31,538
-7,949
-20% -$1.05M 0.04% 401
2026
Q1 		$5.5M Sell
39,487
-2,958
-7% -$414K 0.07% 304
2025
Q4 		$5.21M Buy
42,445
+1,604
+4% +$195K 0.06% 304
2025
Q3 		$4.53M Buy
40,841
+5,711
+16% +$649K 0.06% 321
2025
Q2 		$3.89M Buy
35,130
+5,534
+19% +$589K 0.06% 326
2025
Q1 		$3.32M Buy
29,596
+228
+0.8% +$23.5K 0.06% 339
2024
Q4 		$2.71M Buy
29,368
+1,247
+4% +$112K 0.05% 359
2024
Q3 		$2.36M Sell
28,121
-6,876
-20% -$525K 0.04% 386
2024
Q2 		$2.4M Sell
34,997
-7,202
-17% -$481K 0.05% 351
2024
Q1 		$3.09M Sell
42,199
-4,446
-10% -$342K 0.07% 280
2023
Q4 		$3.78M Buy
46,645
+7,257
+18% +$565K 0.1% 224
2023
Q3 		$2.95M Buy
39,388
+1,319
+3% +$101K 0.09% 239
2023
Q2 		$2.93M Buy
38,069
+2,606
+7% +$208K 0.1% 220
2023
Q1 		$2.94M Buy
35,463
+12,129
+52% +$1M 0.12% 192
2022
Q4 		$2M Sell
23,334
-2,097
-8% -$166K 0.1% 229
2022
Q3 		$1.57M Sell
25,431
-3,711
-13% -$234K 0.09% 253
2022
Q2 		$1.8M Sell
29,142
-2,730
-9% -$169K 0.1% 238
2022
Q1 		$1.9M Buy
31,872
+4,816
+18% +$308K 0.09% 231
2021
Q4 		$1.97M Sell
27,056
-13,479
-33% -$928K 0.09% 228
2021
Q3 		$2.83M Buy
40,535
+2,483
+7% +$174K 0.16% 150
2021
Q2 		$2.62M Buy
38,052
+1,235
+3% +$82.5K 0.16% 145
2021
Q1 		$2.38M Sell
36,817
-1,454
-4% -$93.8K 0.17% 149
2020
Q4 		$2.17M Buy
38,271
+15,917
+71% +$960K 0.16% 149
2020
Q3 		$1.44M Buy
+22,354
New +$1.55M 0.12% 181

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Private Wealth Services's GILD Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its Gilead Sciences (GILD) stake by 20% in Q2 2026, selling an estimated $1.05M and leaving 31,538 shares worth $3.98M. The position accounts for 0.04% of the portfolio, ranked #401.

Kestra Private Wealth Services first reported a position in GILD in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.5M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kestra Private Wealth Services held 31,538 shares of Gilead Sciences worth $3.98M as of Q2 2026.
  • Kestra Private Wealth Services sold 7,949 Gilead Sciences shares in Q2 2026, an estimated $1.05M.
  • Gilead Sciences made up 0.04% of Kestra Private Wealth Services's portfolio in Q2 2026, its #401 holding.
  • Kestra Private Wealth Services first reported a position in Gilead Sciences in Q3 2020 and has held it in 24 quarters since.
  • Kestra Private Wealth Services's Gilead Sciences position peaked at $5.5M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.